Related Experiment Videos

[The study of countermeasures on measles control in infants]

L Wang1, L Sun, Z Jiang

  • 1Senitation and Anti-epidemic Station of Jilin Province. Changchun 130021, China.

Insights

Maternal measles antibody levels are low, impacting newborns. Early infant vaccination at six months may improve protection against measles, reducing illness in infants.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Context:

  • Maternal antibody transfer is crucial for infant immunity.
  • Measles antibody levels in mothers and newborns are often insufficient for sustained protection.
  • Infant vaccination schedules aim to establish protective immunity before maternal antibodies wane.

Purpose:

  • To assess measles IgG antibody levels in mothers and newborns.
  • To evaluate the correlation between maternal and infant measles antibody titers.
  • To determine the efficacy of current infant measles vaccination schedules at 6 and 8 months.
  • To inform measles control strategies for infants.

Summary:

  • Measles IgG antibody levels were measured in 58 mother-newborn pairs using ELISA.
  • Newborns showed low initial measles antibody levels that declined significantly by 3, 6, and 8 months.
  • Vaccination success rates and antibody distribution were similar in 6- and 8-month-old infants, but overall antibody levels remained low, offering minimal protection.
  • Maternal measles antibody levels were generally low, correlating with infant levels.

Impact:

  • Low maternal antibody levels necessitate improved infant immunization strategies.
  • Vaccinating mothers may enhance neonatal measles antibody levels.
  • Shifting the primary measles vaccination age to 6 months could reduce infant measles morbidity in specific regions.
Abstract

Related Concept Videos